Morning Briefing
Summaries of health policy coverage from major news organizations
Man Shot During 2024 Trump Assassination Attempt In Pennsylvania Has Died
AP: Man Shot During 2024 Trump Campaign Rally In Butler, Pennsylvania, Has Died
James Copenhaver, one of three campaign rally attendees shot in 2024 during an assassination attempt on then-candidate Donald Trump, has died in Pittsburgh, his lawyer said Thursday. He was 76. Copenhaver was in the bleachers during the event in Butler, Pennsylvania, when a 20-year-old gunman opened fire from a nearby rooftop, grazing Trump’s right ear with one bullet. Copenhaver was struck in the arm and in the abdomen, wounds that left him with lingering injuries and walking with a cane. (Johnson and Carr Smyth, 9/25)
In other news about the Trump administration —
Becker's Hospital Review: AMA, AHA Seek Exemptions From Proposed $103K H-1B Visa Fee
The American Medical Association and American Hospital Association are asking the Department of Homeland Security to exempt clinicians from a proposed $103,265 fee on H-1B visa petitions. The AMA warned the fee would make recruiting physicians to underserved areas “next to financially impossible.” (Twenter, 9/24)
Military.com: Transgender Service Members Allegedly Denied Promised Separation Pay After Forced Military Exits
A group of Democratic lawmakers want answers from the Pentagon and Defense Secretary Pete Hegseth following reports that roughly a dozen transgender service members never received separation pay following their forced exits from the military. (Mordowanec, 9/25)
The Hill: Students For Life America Files Notice To Sue FDA Over Mifepristone Usage
The anti-abortion group Students for Life of America on Thursday filed a notice of intent to sue the Food and Drug Administration (FDA) over alleged inaction over the Endangered Species Act, an escalation of the group’s years-long effort to use environmental laws to restrict abortion drugs. The organization alleges more than 50 tons of medical waste are flushed into water systems each year as a result of abortion drugs, causing significant environmental harm. Environmental scientists dispute that. (Weixel, 9/24)
CBS News: Will An FDA Crackdown Curb Access To Cheaper GLP-1 Weight-Loss Drugs? Here's What To Know.
The Food and Drug Administration has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." The letter to Empower Pharmacy marks the first time the FDA has waded into a fierce debate about when a pharmacy's legitimate work of customizing a medication crosses the line into mass-copying of patented FDA-approved drugs. (Gilbert, 9/24)
